LOGIN OR REGISTER
Course Library

Recovery in Persons with Schizophrenia: Achieving Outcomes Beyond Symptomatic Remissions - Post Test and Evaluation Only (paper)

Psychiatry
Credits:
1.5 ANCC Contact Hours
Launch Date:
June 21, 2013
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Psychiatric Case Managers, Psychiatric Mental Health Nurses, Psychiatric Nurses

Relevant Terms:

Recovery, Remission, Schizophrenia, Psychosis, Antipsychotics, Psychotic Disorders, Injectables, Patient Adherence, Patient Compliance,

Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN

Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN
Associate Professor
Director of the Psychiatric-Mental Health Master's Program
Yale University School of Nursing
New Haven, CT

Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN is Associate Professor and Director of the Psychiatric-Mental Health Master's Program at the Yale University School of Nursing, New Haven, CT. Dr Moller received her BSN from Mount Marty College, Yankton, SD; her MSN from the University of Nebraska Medical Center College of Nursing (UNMC-CON), Omaha, NE; and her DNP from Case Western Reserve University, Cleveland, OH. She received the honorary Doctor of Humane Letters from Mount Marty College in 2010. Dr Moller is dually licensed as an advanced registered nurse practitioner and as an advanced practice registered nurse. She is also dually certified as a clinical specialist in adult psychiatric-mental health nursing and a psychiatric rehabilitation practitioner.
 
Dr Moller is Past President of the American Psychiatric Nurses Association (APNA), and an invited member of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) Behavioral Health Professional and Technical Advisory Committee, 2012-2014. She has served on two task forces at the National Institute of Mental Health and served as a National Alliance for the Mentally Ill (NAMI) advisor to the Annapolis Coalition. Dr Moller has coauthored over 40 articles and book chapters, made over 900 professional and research presentations, and is a reviewer for Archives of Psychiatric Nursing and Perspectives in Psychiatric Care. Throughout her distinguished career, Dr Moller has received numerous honors and awards including the Professional of the Year Award from NAMI, the keynote address for the Canadian Schizophrenia Society annual meeting in Toronto, Canada, Clinical Excellence awards from APNA, the Association of Advanced Practice Psychiatric Nurses (WA State), and the Nebraska Nurses Association, the Dean's Legacy Award from Case Western Reserve University, and has been inducted as a Fellow in the American Academy of Nursing. 

Mary Ann Nihart, MA, APRN, PMHNP-BC, PMHCNS-BC

Mary Ann Nihart, MA, APRN, PMHNP-BC, PMHCNS-BC
Chief Nurse, Critical Care and Mental Health Services
San Francisco Veterans Administration Medical Center
San Francisco, CA

Mary Ann Nihart, MA, APRN, PMHNP-BC, PMHCNS-BC is currently Chief Nurse of Critical Care and Mental Health Services at the San Francisco Veterans Administration Medical Center, San Francisco, CA. Ms Nihart also teaches at the University of California, Davis, and precepts psychiatric nurse practitioners. She is Chairman of the Board of Directors of Pro-ACT, Inc, a consulting company devoted to reducing the use of seclusion and restraint by promoting safety and dignity through problem-solving. Ms Nihart received her BSN and MA in nursing from the University of Iowa, Cedar Rapids, and an MA in psychology from the California School of Professional Psychology (CSPP, now Alliant International University), San Francisco, CA. Ms Nihart is dually certified as a clinical nurse specialist and nurse practitioner in psychiatric-mental health nursing.
 
In her work at the San Francisco Veterans Administration Medical Center, Ms Nihart has helped expand Behavioral Health Services, integrating the principles of recovery throughout the service and advancing a comprehensive Psychosocial Rehabilitation and Recovery Center (PRRC) with strong community integration. Well published, she is a sought-after lecturer who speaks nationally and internationally, and regularly chairs a large psychiatric nursing conference. She has worked on several projects for the Substance Abuse Mental Health Services Administration (SAMHSA), including disaster mental health, restraint reduction, and trauma-informed care. Ms Nihart served six years on the Board of Directors of the National Association of Nurse Practitioners in Women's Health, is a Past President of the California Chapter of the American Psychiatric Nurses Association (APNA), and currently serves on the APNA Institute for Mental Health Advocacy and the conference committee of the APNA Clinical Psychopharmacology Institute. Ms Nihart has received multiple awards, including the Association of Advanced Practice Psychiatric Nurses (AAPPN) Nursing Excellence Award in the State of Washington and the Outstanding Service Award from UC Davis. She is the 2012 APNA Psychiatric Nurse of the Year.

Lisa Strimple-Padios

Lisa Strimple-Padios
Mental Health Consumer
Omaha, NE

Lisa Strimple-Padios is a person with lived experience of schizophrenia since age 17. Living through several losses, she suffered symptoms as a young child and adolescent and had her first hospitalization at 15 for a suicide attempt. She dropped out of school after the 8th grade, but later attained her GED at age 17. Lisa and her husband Bob have been married for 39 years and have two grown children, a son who is a successful attorney and a daughter who is an award-winning photographer. Between them, she has 9 grandchildren. Lisa attended 2.5 years of college hoping to become a sociologist or a nurse, however, hospitalizations and symptoms interrupted her college career. She eventually completed a CNA course and worked as a certified nursing assistant for two years.

Over her lifetime, Lisa has had over 40 hospitalizations, including several for treatment of severe asthma. Her psychiatric hospitalizations total over 5 years of her life. One hospitalization in particular lasted over one year and included 9 days in restraints and nearly daily seclusion over a three-month period. Lisa has been on nearly every psychotropic drug in the formulary and has experienced numerous severe side effects. Eight years ago she experienced lithium toxicity due to a year-long combination of an NSAID for arthritis and lithium in addition to antipsychotic medications. As a result, she has permanent cognitive and balance deficits.

Lisa attributes her recovery to the support of her family and a consumer support group, the right medications, psychoeducation, and her Christian faith. She is a consumer co-facilitator of The Three R's Psychiatric Wellness Rehabilitation Program, having assisted with 6 national two-week train-the-trainer programs. She has lectured to undergraduate nursing students for over 20 years. Lisa has appeared in three professional training videotapes. She served on the Board of Directors of Nebraska Advocacy Services for 3 years and is an active member of the National Alliance for the Mentally Ill (NAMI).
1. Assess the key elements of recovery and its differentiation from remission
2. Describe the impact of relapse on functional outcomes and the essential components of a relapse prevention plan
3. Evaluate the limitations of current strategies used in the management of schizophrenia and develop individualized, self-management programs that support mental health consumers in the recovery process

Program Overview
Schizophrenia is a chronic and severe mental disease that affects 26 million people worldwide, resulting in significant morbidity, an increased risk of mortality, moderate to severe disability in 60% of cases, and an estimated U.S. annual cost of $65 billion. Much of this burden is associated with frequent relapses and hospitalizations, in part because of suboptimally controlled symptoms, medication interventions and follow-through, and an absence of relapse prevention plans. In this activity, expert faculty will follow a mental health consumer through various phases of treatment. Commentary from the mental health consumer will be incorporated throughout the activity in order to provide a unique perspective on the challenges of schizophrenia and insights on how psychiatric mental health nurses can best support optimal outcomes.

Accreditation Statements
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This program is approved for 1.5 continuing nursing education contact hours by the American Psychiatric Nurses Association.

Disclosure of Conflicts of Interest
The American Psychiatric Nurses Association (APNA) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by APNA for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Mary Ann Nihart, MA, APRN, PMHNP-BC, PMHCNS-BC, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Lisa Strimple-Padios has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

The following APNA staff serve as clinical content reviewers and/or participate in planning CE activities in a manner that may affect content: Patricia Black, PhD (c), RN; Deborah Hobbs, PhD, RN, hereby state that they or their spouse do not have any financial relationships with any commercial interests related to the content of this CE activity of any amount during the past 12 months.

The following Spire Learning staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content: Kashemi D. Rorie, PhD and Jeanne Prater hereby state that they do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CE activity of any amount during the past 12 months. The spouse of Jeanne Prater, is an employee of Novo Nordisk and stockholder of Johnson & Johnson.

Method of Participation and Request for Credit
There are no additional fees for participating and receiving CE credit for this activity. If you wish to receive full credit for participating in this activity, you must attend the entire session and complete its pre/post-test and evaluation. A CE certificate will be generated online and available for you to print. We cannot award credit unless all steps are completed.

Off-label Product Disclosure
This educational activity does not include the discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration.
 
General Disclosure and Copyright Statement
The opinions expressed in this activity are those of the participating faculty and not those of the American Psychiatric Nurses Association, Spire Learning or any manufacturers of products mentioned herein.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Copyright 2013. American Psychiatric Nurses Association and Spire Learning. All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the American Psychiatric Nurses Association and Spire Learning.
 
The American Psychiatric Nurses Association and Spire Learning reserve the right to cancel or modify the activity content, faculty, and activities if necessary.

This educational activity is co-provided by the American Psychiatric Nurses Association and Spire Learning.
  

This activity is supported by an unrestricted educational grant from Otsuka America Pharmaceutical, Inc.

Schedule an event with a Standardized Patient
×